Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PharmaEssentia
PharmaEssentia
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Besremi
Ropeginterferon alfa-2b
2021-11-12
Polycythemia vera
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ropeginterferon alfa-2b
myeloid leukemia chronic-phase
,
polycythemia vera
,
polycythemia
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
essential thrombocythemia
,
thrombocytosis
Gilvetmab
ovarian neoplasms
,
kidney neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
hematologic diseases
,
myelomonocytic leukemia chronic
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
gastrointestinal stromal tumors
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
head and neck neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
thymoma
,
intestinal neoplasms
,
thymus neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
triple negative breast neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
renal cell carcinoma
,
lung neoplasms
,
liver neoplasms
,
lymphoma
,
breast neoplasms
,
ovarian epithelial carcinoma
,
sarcoma
,
squamous cell carcinoma of head and neck
,
anus neoplasms
,
small cell lung carcinoma
,
adenocarcinoma
,
squamous cell neoplasms
,
mesothelioma
,
pancreatic ductal carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
pancreatic neoplasms
,
esophageal neoplasms
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
clear cell adenocarcinoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
neuroendocrine tumors
,
urologic neoplasms
,
thyroid neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
neoplasm metastasis
,
hematologic neoplasms
,
anaplastic thyroid carcinoma
,
malignant mesothelioma
,
neuroendocrine carcinoma
,
melanoma
,
skin neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use